Autoimmune Disease clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
“Assessing new blood cells growth after transplant using cord blood units that do not meet FDA guidelines but meet NMDP guidelines”
open to all eligible people
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
at UCLA UCSD UCSF
Our lead scientists for Autoimmune Disease medical studies include Gary Schiller, MD Thomas Martin, MD Mark Walters, MD.